INDICATORS ON IL-2 THERAPY FOR MELANOMA YOU SHOULD KNOW

It is actually properly understood that IL-two is often a pleiotropic cytokine positioned in the crossroads of T cell activation and regulation. Therefore, it is actually very important to engineer an IL-2 molecule which is biased to effector cells bearing the intermediate affinity receptor, for instance naïve and memory CD8+ T cells and NK cells,